Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 10, 2014 | Supplemental Material + Published
Journal Article Open

Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function

Abstract

Iron excess is closely associated with tumorigenesis in multiple types of human cancers, with underlying mechanisms yet unclear. Recently, iron deprivation has emerged as a major strategy for chemotherapy, but it exerts tumor suppression only on select human malignancies. Here, we report that the tumor suppressor protein p53 is downregulated during iron excess. Strikingly, the iron polyporphyrin heme binds to p53 protein, interferes with p53-DNA interactions, and triggers both nuclear export and cytosolic degradation of p53. Moreover, in a tumorigenicity assay, iron deprivation suppressed wild-type p53-dependent tumor growth, suggesting that upregulation of wild-type p53 signaling underlies the selective efficacy of iron deprivation. Our findings thus identify a direct link between iron/heme homeostasis and the regulation of p53 signaling, which not only provides mechanistic insights into iron-excess-associated tumorigenesis but may also help predict and improve outcomes in iron-deprivation-based chemotherapy.

Additional Information

© 2014 The Authors Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Received: August 7, 2013 Revised: December 2, 2013. Accepted: February 27, 2014. Published: March 27, 2014. We gratefully acknowledge Dr. Alexander Varshavsky (California Institute of Technology) for his generous support, encouragement in initiating the project, and advice on manuscript preparation. The authors are particularly thankful to Dr. Bert Vogelstein (Johns Hopkins University) for his critical reading of the manuscript, generous support, and sharing key reagents. The plasmid encoding GST-CRM1/XPO1 was a gift from Dr. Chuanmao Zhang (Peking University). This work was supported by funding from the National Science Foundation of China to R.H. (31270828 and 31070678) and grants from the Ministry of Science and Technology, China (2010CB912101, 2012CB910800, and 2013CB910900 to R.H. and 2011CB915501 to K.R.). R.H. was also supported by a Sanofi-aventis SIBS Young Investigator award and funding from the Cancer Center of Xuhui Central Hospital (CCR2012003), Shanghai Institute of Neurosciences (SKLN-201206), and Shanghai Municipal Department of Science and Technology (PJ[2010] 00123). We are grateful to Drs. Dangsheng Li and Lin Li (SIBCB), Zhenggang Liu (National Cancer Institute), and Douglas Rees (California Institute of Technology) for helpful discussions. We also thank Dr. Yongguang Gao for his help in image processing.

Attached Files

Published - 1-s2.0-S2211124714001569-main.pdf

Supplemental Material - mmc1.pdf

Supplemental Material - mmc2.pdf

Files

mmc2.pdf
Files (13.4 MB)
Name Size Download all
md5:60483bf86ff87cee4d2349c507889d89
6.7 MB Preview Download
md5:a0474338a145c8537dd282913c7dc571
4.6 MB Preview Download
md5:ffc1b0889ab2c4145791f6e03183c2ec
2.0 MB Preview Download

Additional details

Created:
August 20, 2023
Modified:
October 26, 2023